1. News & Events
  2. Blog

Blog

Incyte collaboration with Vanderbilt is all about the connection

Incyte collaboration with Vanderbilt is all about the connection

New method to thwart false positives in CT-lung cancer screening

A team of investigators led by Fabien Maldonado, MD, associate professor of Medicine at Vanderbilt, and Tobias Peikert, MD, assistant professor of Medicine at Mayo Clinic, Rochester, Minnesota, has identified a new technology to address false positives in CT-based lung cancer screening. The study was published in the latest issue of PLOS One.

New target to stop Ebola

Ebola is a severe and often fatal hemorrhagic fever affecting humans that can be caused by four known Ebola viruses.

Several attempts have been made to prevent the spread of Ebola, including development of an antibody cocktail called “ZMapp.” However, ZMapp is effective against only onemember of the Ebola virus family — Zaire ebolavirus.

Student entrepreneurs can apply today for 36|86: Student Edition

Applications for 36|86: Student Edition, a pitch competition for student entrepreneurs seeking access to funding, market support and community and corporate resources, are open through June 4.

“These could revolutionize the world” — Pint cracks code to cheap, small carbon nanotubes

Imagine a box you plug into the wall that cleans your toxic air and pays you cash.

That’s essentially what Vanderbilt University researchers produced after discovering the blueprint for turning the carbon dioxide into the most valuable material ever sold – carbon nanotubes with small diameters.

Applications Open for AgLaunch Bootcamp for Tennessee Agricultural Innovation Startups

Vanderbilt signs license agreement with student startup Path Ex

Vanderbilt signs license agreement with student startup PATH EX

Related Categories: 
Sinead Miller Path Ex sepsis license agreement startup

Getting robotic surgical tools from the lab to the operating room

Getting robotic surgical tools from the lab to the operating room

Three Vanderbilt technologies earn patent protection

Three new Vanderbilt technologies earn patent protection in April.

9,950,096     Particle/polyurethane composites and methods thereof

Vanderbilt research lab honored by World Vaccine Congress

The laboratory of James Crowe Jr., MD (pictured), director of the Vanderbilt Vaccine Center, received the 2018 Vaccine Industry Excellence Award for Best Academic Research Team at the 18th World Vaccine Congress in Washington, DC, this week.